NCT00278772View on ClinicalTrials.gov

Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
Interventions
DRUG

Divalproex

oral, 15mg/kg/day - 30mg/kg/day

OTHER

Placebo

oral dose, placebo

Trial Locations (1)

45267-0559

University of Cincinnati Medical Center, Cincinnati

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER

NCT00278772 - Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania | Biotech Hunter | Biotech Hunter